Candidemia chronicles: Retrospective analysis of candidemia epidemiology, species distribution, and antifungal susceptibility patterns in Bahrain

Table 3 Antifungal susceptibility for the most common fungal strains detected from patients with fungaemia

Candida species	Year	Number	Age (years)	Male:female	Death	Amphotericin B	5-fluorocytosine	Fluconazole	Voriconazole	Posaconazole	Itraconazole	Micafungin	Anidulafungin	Caspofungin
Candida albicans	2021	48	65.1 ± 18	0.7	89.5	100	N/A	87.5	79	68.2	75	13	21	100
	2022	24	71.6 ± 18.7	1.2:1	77.3	100	N/A	63.6	63.6	45.5	45.5	54.5	36.4	100
	2023	33	66.5 ± 15.6	1.5:1	80	100	N/A	52.3	71.4	66.6	36.4	13.6	13.6	100
	Total	103	66 ± 18.8	1:1	83	100	N/A	71	74.5	62.2	51	21.4	21	100
Candida tropicalis	2021	31	66.6± 14.7	1.9:1	89.6	100	N/A	15.7	10.5	5.5	10.5	N/A	0	0
	2022	29	65.6 ± 22	0.93	72	82	N/A	9	9	0	0	N/A	0	0
	2023	23	67.4 ± 19.4	1.1:1	92	100	N/A	0	0	0	0	0	0	0
	Total	83	67± 18.3	1.2:1	83	95.5	N/A	8.8	6.6	2.2	4.6	0	0	0
Candida parapsilosis	2021	27	61.2 ± 22.2	1.3:1	92	100	N/A	82	100	91	100	100	100	100
	2022	36	70.4 ± 14.9	1.1:1	87	100	N/A	68	95	95	95	100	100	100
	2023	29	61.7 ± 20.6	0.93:1	85.7	100	N/A	76.5	94	94	88.2	100	100	100
	Total	93	64.9 ± 196	1.1:1	88.5	100	N/A	75.7	95.6	93.7	93.2	100	100	100
Candida glabrata	2021	18	64.2 ± 13.7	2.2:1	94.7	100	N/A	0	N/A	N/A	N/A	100	54	54
	2022	7	70.6 ± 11.7	2.5:1	66.6	100	N/A	0	N/A	N/A	N/A	100	100	100
	2023	10	64.3	1:4	100	100	N/A	0	N/A	N/A	N/A	100	100	100
	Total	35	65.4 ± 15.4	1.25:1	88.8	100	N/A	0	N/A	N/A	N/A	100	64	64
Candida auris	2021	13	67.5 ± 21	1.2:1	100	100	N/A	0	N/A	N/A	N/A	87.5	87.5	87.5
	2022	38	72.4 ± 15.5	1.5:1	85.3	100	N/A	4	N/A	N/A	N/A	100	100	0
	2023	27	58.3 ± 18.9	0.93:1	100	100	N/A	0	N/A	N/A	N/A	100	100	4.5
	Total	78	66.6 ± 18.8	1.2:1	87.5	100	N/A	2	N/A	N/A	N/A	98	98	13.2